Using this experimental system we found an ordered sequence of events that preceded the emergence of chemoresistance, which could essentially be recapitulated with TP53-mutated IGROV-1 cells, an ovarian cancer cell line most likely of low-grade serous adenocarcinoma origin [53, 56]. The gene discussed is TP53; the disease is ovarian cancer.